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Abstract
Background: Plant phenolics are important nutritional antioxidants which could aid in overcoming chronic
diseases such as cardiovascular disease and cancer, two leading causes of death in the world. The oil palm (Elaeis
guineensis) is a rich source of water-soluble phenolics which have high antioxidant activities. This study aimed to
identify the in vivo effects and molecular mechanisms involved in the biological activities of oil palm phenolics
(OPP) during healthy states via microarray gene expression profiling, using mice supplemented with a normal diet
as biological models.
Results: Having confirmed via histology, haematology and clinical biochemistry analyses that OPP is not toxic to
mice, we further explored the gene expression changes caused by OPP through statistical and functional analyses
using Illumina microarrays. OPP showed numerous biological activities in three major organs of mice, the liver,
spleen and heart. In livers of mice given OPP, four lipid catabolism genes were up-regulated while five cholesterol
biosynthesis genes were down-regulated, suggesting that OPP may play a role in reducing cardiovascular disease.
OPP also up-regulated eighteen blood coagulation genes in spleens of mice. OPP elicited gene expression changes
similar to the effects of caloric restriction in the hearts of mice supplemented with OPP. Microarray gene
expression fold changes for six target genes in the three major organs tested were validated with real-time
quantitative reverse transcription-polymerase chain reaction (qRT-PCR), and the correlation of fold changes
obtained with these two techniques was high (R
2 = 0.9653).
Conclusions: OPP showed non-toxicity and various pleiotropic effects in mice. This study implies the potential
application of OPP as a valuable source of wellness nutraceuticals, and further suggests the molecular mechanisms
as to how dietary phenolics work in vivo.
Background
The continuous improvement in the quality of life in
recent years, together with the advancement of science
and technology, has created a more health-conscious
society. Data from large population studies suggest that
lifestyle factors, such as sedentary lifestyle, dietary intake
and adiposity are responsible for 70% of chronic diseases
and are a major contributor to reduced longevity [1].
Thus, society now realises the importance of physical
activity and dietary intervention towards the prevention
of chronic diseases and ageing. Chronic diseases such as
cardiovascular disease and cancer are by far the leading
cause of mortality in the world, representing 60% of all
deaths [2].
Prooxidants such as reactive oxygen species (ROS)
play important roles in triggering chronic diseases. For
example, the hydroxyl radical causes lipid peroxidation,
modification of DNA bases or protein damage and in
turn, leads to tissue damage, chronic diseases and ageing
[3]. In addition to oxidising macromolecules such as
DNA in the body, prooxidants have been found to regu-
late gene expression, of which two well-defined tran-
scription factors, nuclear factor kappa-B and activator
protein-1 are affected, causing inflammation [4]. Inflam-
mation thus links oxidative stress with chronic diseases.
Many studies conducted recently have shown that
diets containing high amounts of phytochemicals can
provide protection against these prooxidant-induced dis-
eases, due to their high antioxidant activities.
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damage by preventing the formation of these prooxi-
dants, by scavenging them or by promoting their
decomposition [3]. Antioxidants are also found to be
caloric restriction mimetics, the only intervention
known to lengthen the median lifespan of animals [5].
Among the different groups of naturally occurring anti-
oxidants from plants, carotenoids and phenolics are per-
haps the two most important [6]. Phenolics comprise an
aromatic ring, and are important antioxidants because
of their high redox potential, which allows them to act
as reducing agents, hydrogen donors, singlet oxygen
quenchers and metal chelators [6]. Around 8000 pheno-
lic compounds have been identified thus far, and they
have been classified into different categories based on
their basic structures [7]. Phenolics possess many thera-
peutic properties. For example, flavonoids have been
shown to have antioxidant, neuroprotective, cardiopro-
tective, lipid-lowering, anti-hepatotoxic, anti-allergic,
anti-cancer, anti-inflammatory, anti-thrombotic and
anti-microbial activities [8].
Besides their antioxidant properties, phytochemicals
such as phenolics are also known to influence gene
expression [9]. Microarray analysis has thus been sug-
gested as a tool to identify modulations of multiple gene
networks by antioxidant micronutrients [10], as the
expression profiles of thousands of genes can be mea-
sured in a single experiment [11]. As dietary interven-
tion generally results in small effects on a big number of
genes compared to pharmaceutical intervention which
targets a specific biomarker, microarrays can therefore
detect a combined effect of several genes belonging to a
similar biological pathway [12]. Indeed, multi-compo-
nent botanical therapeutics such as phenolics may
become particularly valuable in the long-term preven-
tion and treatment of complex diseases requiring
extended administration and pleiotropic action [13]. In
studies on plant phenolics, microarray studies have been
carried out to test the biological effects of flavonoids in
cultured cell lines in vitro [14,15] as well as in animals
in vivo [12].
The oil palm (Elaeis guineensis) contains an excellent
repertoire of antioxidant phytochemicals. Palm fruit oil
contains many lipid-soluble antioxidants, such as carote-
noids (precursors of vitamin A ) ,a sw e l la st o c o p h e r o l s
and tocotrienols (isomers of vitamin E) [16-18]. Another
relatively new antioxidant phytochemical from the oil
palm fruit is the water-soluble phenolic acid-rich com-
plex, which is recovered from the oil palm vegetation
liquor through a series of centrifugation and membrane
filtration steps [19]. These oil palm phenolics (OPP)
consist mainly of phenolic acids, including three caf-
feoylshikimic acid isomers, protocatechuic acid and p-
hydroxybenzoic acid [20,21]. OPP has been shown to
display antioxidant properties and confer positive out-
comes on degenerative diseases in various animal mod-
els without evidence of causing toxicity [21-23]. The
utilisation of OPP in the nutraceutical market is how-
ever, subject to understanding the molecular mechan-
isms involved in bringing about the positive benefits
observed, whether in healthy or diseased states. The aim
of this study was thus to identify the in vivo biological
effects and molecular mechanisms of these compounds
during healthy states in three major organs (liver, spleen
and heart) of mice on a normal diet, via microarray
gene expression profiling.
Results
Weight gain delay and non-toxicity in mice supplemented
with OPP
We first confirmed that OPP was not toxic to mice via
physiology, histology, haematology and clinical biochem-
istry analyses. The body weights of mice steadily
increased every week throughout the six weeks of feed-
ing, with mice given OPP showing a delayed weight gain
(Figure 1A). OPP did not significantly affect organ
weights (Figure 1B), fluid intake (Figures 1C and 1D),
food intake (Figures 1E and 1F), faecal output (Figures
1G and 1H), organ histology (Figure 2), as well as hae-
matology and clinical biochemistry (Table 1) parameters.
Overview of gene expression changes in the liver, spleen
and heart
Illumina microarrays were used to study the effects of
OPP in the livers, spleens and hearts of mice given a
normal diet. OPP significantly changed 250 genes in the
liver (196 genes up-regulated and 54 genes down-regu-
lated), 142 genes in the spleen (100 genes up-regulated
and 42 genes down-regulated), and 475 genes in the
heart (196 genes up-regulated and 279 genes down-
regulated). The number of genes significantly changed
by OPP was thus highest in the heart, followed by the
liver and the spleen. The lists of genes significantly
changed by OPP in these organs, together with their
fold changes, are supplemented in Additional File 1.
T h ee f f e c t so fO P Po nt h eo r g a n st e s t e dw e r eq u i t e
subtle. The majority of the differentially expressed genes
rarely exceeded two fold change in expression, with the
exception of genes considered turned on (significantly
detected only in the treatment group) or off (signifi-
cantly detected only in the control group). The large
fold changes observed in this particular group of genes
(turned on or off) are arbitrary values as values of 10
were assigned when negative expression values were
observed after normalisation. These results indicate that
OPP can act as regulators of gene expression, turning
on and silencing genes. In addition, the low fold changes
caused by OPP indicate that they do not have drastic
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as dietary supplements. Such supplements should not
bring too drastic a change in the system of an organism,
but rather act as an antioxidant buffer to cushion the
effects of other environmental influences such as prooxi-
dant production.
An example of the two-way hierarchical clustering
analysis carried out on significantly changed genes in
the liver is given in Additional File 2. The replicates of
each condition were clustered to one another, indicating
robustness of the filtering criteria used. In order to get
an overview of the significant functions affected by OPP,
we then subjected the microarray data to functional
enrichment analysis using the GenMAPP [24] and
MAPPFinder [25] softwares (University of California at
San Francisco, San Francisco, CA). The lists of these
Figure 1 Physiology parameters of mice. (A) Body weights; n = 10. (B) Organ weights; n = 10. (C) Timeline of fluid intake; n = 2 cages (of 5
mice per cage). (D) Average daily fluid intake; n = 42 days. (E) Timeline of food intake, n = 2 cages (of 5 mice per cage). (F) Average daily food
intake between week two to week three; n = 7 days. (G) Timeline of faecal output, n = 2 cages (of 5 mice per cage). (H) Average daily faecal
output between week two to week three; n = 7 days. # P < 0.05 vs. Normal Diet + Distilled Water. Error bars indicate s.e.m.
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tional File 3. By exploring functions which were consid-
ered significantly changed, we further selected
GenMAPPs which were considered interesting for path-
way analysis. Network analysis was also carried out on
the differentially expressed genes by using the Ingenuity
Pathways Analysis software (Ingenuity
® Systems, Red-
wood City, CA) [26].
Gene expression changes in the liver
In the GenMAPPs and gene ontologies found signifi-
cantly changed in the liver, those related to fatty acid
Figure 2 OPP did not affect organ histology. Representative haematoxylin and eosin stained tissue slices from the three major organs in each
group were viewed under a light microscope with a magnification of X200. (A) Liver. (B) Spleen. (C) Heart.
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Page 4 of 17beta oxidation (for up-regulated genes) and cholesterol
biosynthesis (for down-regulated genes), were predomi-
nant. Further analysis on the fatty acid beta oxidation
GenMAPP (pathway) revealed the up-regulation of
genes such as those encoding long chain acetyl-CoA
dehydrogenase (Acadl), short chain acyl-CoA dehydro-
genase (Acads) and hydroxyacyl-CoA dehydrogenases
(Hadhb, Hadhsc) (Figure 3A). These significantly up-
regulated genes are highlighted in yellow.
Other functions which were significantly up-regulated
by OPP in the liver were complement activation, protein
biosynthesis and transport, ion and electron transport as
well as translation factors. Up-regulated genes involved
in complement activation include C1r, C1rl, C1s, C4, C9
and Cfhl1. In addition, genes involved in ion and electron
transport such as those encoding cytochromes P450
involved in phase I metabolism (Cyp1a2, Cyp27a1,
Cyp2a12, Cyp2c54, Cyp2d26, Cyp3a11) and NADH dehy-
drogenase (ubiquinone) Fe-S proteins (Ndufs2, Ndufs3),
were up-regulated. Genes involved in phase II metabo-
lism such as those encoding UDP glycosyltransferases
(Ugt1a6 and Ugt1a9) and catechol-O-methyltransferase
(Comt), were up-regulated as well. Translation factors
involved in protein synthesis (Eef1d, Eef2, Eif3s2, Eif3s8,
Eif4a2, Eif5a) were also up-regulated by OPP.
Genes involved in cholesterol biosynthesis on the
other hand, such as those encoding lanosterol synthase
(Lss), sterol-C4-methyl oxidase-like (Sc4mol), farnesyl
diphosphate synthetase (Fdps), NAD(P) dependent ster-
oid dehydrogenase-like (Nsdhl) and 3-hydroxy-3-methyl-
glutaryl-CoA synthase 1 (Hmgcs1) were down-regulated
(Figure 3B). In this pathway, besides those highlighted
in blue (genes which were significantly down-regulated),
other genes in the pathway had negative fold changes,
the most important being Hmgcr (hydroxymethylglu-
taryl-CoA reductase), a gene targeted by drugs such as
statins for lowering cholester o l .T h ef o l dc h a n g ed i f f e r -
ence of this gene was however, not significant due to
the filtering criteria used.
Gene expression changes in the spleen
A majority of the genes significantly up-regulated in the
spleen were part of the blood coagulation network (Fig-
ure 4). Some of the up-regulated genes were those
Table 1 Haematology and clinical biochemistry parameters of mouse blood samples
Test Normal Diet +
Distilled Water
Normal Diet +
Oil Palm Phenolics
Haematology (n=4 )( n=4 )
Red Blood Cells (X10
12/L) 9.93 ± 0.32 10.15 ± 0.12
Haemoglobin (g/L) 148 ± 4 149 ± 1
Haematocrit/Packed Cell Volume (L/L) 0.40 ± 0.01 0.40 ± 0.00
Mean Corpuscular Volume (fL) 41 ± 1 40 ± 0
Mean Corpuscular Haemoglobin Concentration (g/L) 369 ± 6 373 ± 4
White Blood Cells (X10
9/L) 2.0 ± 0.6 1.5 ± 0.3
Band Neutrophils (X10
9/L) 0.05 ± 0.01 0.04 ± 0.01
Segmented Neutrophils (X10
9/L) 0.48 ± 0.17 0.35 ± 0.09
Lymphocytes (X10
9/L) 1.36 ± 0.38 1.01 ± 0.20
Monocytes (X10
9/L) 0.09 ± 0.02 0.07 ± 0.02
Eosinophils (X10
9/L) 0.03 ± 0.01 0.01 ± 0.00
Basophils (X10
9/L) 0.00 ± 0.00 0.00 ± 0.00
Thrombocytes (X10
9/L) 533 ± 111 621 ± 103
Prothrombin (g/L) 79 ± 2 80 ± 1
Clinical Biochemistry (n=8 )( n=7 )
Alanine Aminotransferase (U/L) 34.4 ± 3.3 42.5 ± 6.5
Aspartate Aminotransferase (U/L) 175.2 ± 23.8 240.4 ± 22.3
Glucose (mmol/L) 6.0 ± 1.1 6.7 ± 0.4
Serum Total Protein (g/L) 53.8 ± 1.8 53.8 ± 1.1
Albumin (g/L) 34.0 ± 0.9 33.1 ± 1.3
Globulin (g/L) 19.8 ± 1.1 20.8 ± 0.8
Albumin:Globulin 1.8 ± 0.1 1.6 ± 0.1
Total Cholesterol (mmol/L) 3.46 ± 0.13 3.53 ± 0.19
Triglycerides (mmol/L) 1.05 ± 0.08 1.04 ± 0.11
Low-Density Lipoproteins (mmol/L) 0.15 ± 0.02 0.18 ± 0.03
High-Density Lipoproteins (mmol/L) 2.79 ± 0.11 2.83 ± 0.17
Values shown are means ± s.e.m. Statistical analysis did not show significant differences in all the parameters measured.
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selectin (Selp), CD9 antigen (Cd9), integrin alpha 2b
(Itga2b), multimerin 1 (Mmrn1), various glycoproteins
(Gp1ba, Gp1bb, Gp5, Gp6, Gp9) and thrombin receptors
(F2rl2, F2rl3). These genes are indicated in red in the
blood coagulation network.
While a pathway involves the metabolism of biochem-
ical compounds catalysed by enzymes, a network
Figure 3 GenMAPPs showing functions and genes significantly changed by OPP in the liver. (A) Genes up-regulated in the liver fatty acid
beta oxidation pathway. This GenMAPP represents an overview of three individual fatty acid beta oxidation GenMAPPs, and shows the up-
regulation of fatty acid beta oxidation genes such as acetyl-CoA dehydrogenase (Acadl), acyl-CoA dehydrogenase (Acads) and hydroxyacyl-CoA
dehydrogenases (Hadhb, Hadhsc). (B) Genes down-regulated in the liver cholesterol biosynthesis pathway. Note that the fold changes for most
of the genes in this GenMAPP were negative, indicating down-regulation, even for genes which were not selected as significantly different
based on the selection criteria used. Also note that Hmgcr which encodes for 3-hydroxy-3-methylglutaryl-CoA reductase, an enzyme inhibited by
cholesterol-lowering statins, showed a negative fold change as well, although the value was not statistically significant.
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network analysis may thus help to detect other possible
proteins affected by the treatment. For example, a num-
ber of coagulation factors (F2, F5, F8, F9, F11)w a s
found to be connected to the genes significantly up-
regulated in the spleen blood coagulation network.
These genes might thus be up-regulated and contribute
to the blood coagulation process observed in this experi-
ment as well, although the statistical threshold used
might not result in these genes being selected as signifi-
cantly changed. A network analysis can also help in the
identification of central regulators in specific networks.
Figure 4 Genes involved in the spleen blood coagulation network which were up-regulated by OPP. The up-regulation of various genes
involved in blood coagulation such as those encoding Von Willebrand factor homologue (Vwf), P-selectin (Selp), various glycoproteins (Gp1ba,
Gp1bb, Gp5, Gp6, Gp9) and thrombin receptors (F2rl2 and F2rl3), suggests a possible effect of OPP in clearing blood clots from the circulation via
the spleen.
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regulator in the blood coagulation network, and might
thus play a central role in this process by up-regulating
the other genes in response to OPP treatment.
In addition to blood coagulation, other functions sig-
nificantly up-regulated in the spleen by OPP include
actin binding, calcium ion binding, cell adhesion, fatty
acid metabolism, focal adhesion, prostaglandin synthesis
regulation, sugar binding and tumour necrosis factor
binding. Genes down-regulated in the spleen on the
other hand, were involved in DNA replication, interleu-
kin-9 signalling, nitrogen metabolism and unfolded pro-
tein binding.
Gene expression changes in the heart
In the heart, genes up-regulated by OPP were involved
in acetyl-CoA, butanoate, fatty acid and lipid metabo-
lisms, golgi organisation and biogenesis, glutathione
metabolism, magnesium ion binding, nitric oxide
mediated signal transduction and translation factors.
Down-regulated genes in the heart include those
involved in energy production, such as the tricarboxylic
acid (TCA) cycle (Figure 5A) and the electron transport
chain (Figure 5B). Genes involved in protein biosynth-
esis such as chromatin assembly or disassembly, haem
biosynthesis, mitochondrial genome maintenance,
mRNA processing and binding, as well as those encod-
ing ribosomal proteins, were also down-regulated.
In the heart TCA cycle, a key enzyme, pyruvate dehy-
drogenase kinase isoenzyme 4 (Pdk4), which inhibits
pyruvate dehydrogenase and thus minimises carbohy-
drate oxidation by preventing the flow of glycolytic pro-
ducts into the TCA cycle, was up-regulated. In
conjunction with this, the expression of other genes
involved in the heart TCA cycle, such as those which
produce NADH (Mdh1) and FADH2 (Shdb), were
down-regulated as well. Suclg1 and Sucla2, genes encod-
ing subunits of succinate-CoA ligases which convert
guanosine triphosphate/adenosine triphosphate (GTP/
ATP) to guanosine diphosphate/adenosine diphosphate
(GDP/ADP) were also down-regulated.
In the heart electron transport chain, Ucp3,ag e n e
encoding an uncoupling protein which protects against
mitochondrial oxidative damage by reducing the pro-
duction of ROS, was up-regulated as well. On the other
hand, genes in the electron transport chain which
encode proteins in Complex I (Ndufb2, Ndufb4,
Ndufb10, Ndufc2, Ndufs4), Complex II (Sdhb)a sw e l la s
those in Complex V (Atp5fi, Atp5j, Atp5k, Atp6v0c,
Atp6v1d), were down-regulated.
Real-time qRT-PCR validation
To confirm the microarray results, the expression levels
of six target genes (Table 2) were measured using real-
time quantitative reverse transcription-polymerase chain
reaction (qRT-PCR). Expression levels of these target
genes were normalised to the geometric mean of three
housekeeping genes, Sfrs9, Guk1 and Hnrpab. The direc-
tion and magnitude of fold changes of the target genes
obtained from the real-time qRT-PCR technique were
comparable to those obtained from the microarray tech-
nique (Figure 6A). Correlation of fold changes obtained
by the two gene expression profiling techniques was
high (R
2 = 0.9653) (Figure 6B), thus indicating that the
microarray data obtained were valid.
Discussion
As OPP displayed significant antioxidant activities and
conferred positive outcomes in various animal models of
degenerative diseases without causing toxicity [21-23],
we hypothesised that it might also have significant bio-
logical effects in animals during healthy states. Thus, we
fed BALB/c mice a normal diet with OPP for six weeks
and looked for signs of toxicity to confirm that OPP is
safe. Microarray gene expression analysis was then car-
ried out on three major organs, the liver, spleen and
heart. This study thus represents an important step
towards understanding the mode of action of OPP dur-
ing healthy states, before further studies are carried out
to identify the molecular mechanisms involved during
diseased states.
OPP up-regulated fatty acid beta oxidation genes and
down-regulated cholesterol biosynthesis genes in the
liver
In identifying the in vivo gene expression changes
caused by any dietary intervention via microarray analy-
sis, the liver naturally becomes the target organ of inter-
est [27,28]. This is because it is a vital organ for various
metabolic functions, including detoxification and pro-
duction of biochemicals necessary for digestion and
maintenance of body processes. In this study, functional
enrichment analysis on the microarray data from the
liver showed that OPP up-regulated several pathways,
including lipid catabolism (fatty acid beta oxidation),
complement activation, protein biosynthesis and trans-
port, ion and electron transport as well as translation
factors.
As the liver is an important site for fatty acid beta oxi-
dation, up-regulation of hepatic lipid catabolism may
contribute to the suppression of liver fat and visceral fat
accumulation. Stocker and Keaney (2004) suggested that
removal of lipids from the body through fatty acid beta
oxidation may prevent lipid peroxidation which contri-
butes to atherosclerosis [29]. Interestingly, enhanced
hepatic fatty acid synthesis and reduced fatty acid oxida-
tion have also been implied in the development of alco-
hol-induced fatty liver [30-33]. Thus, OPP may also be
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Page 8 of 17Figure 5 GenMAPPs showing functions and genes significantly changed by OPP in the heart. (A) Genes up-regulated and down-
regulated in the heart tricarboxylic acid (TCA) cycle. Pdk4, which is involved in fuel selection in the heart by inhibiting pyruvate dehydrogenase
and preventing the metabolic shift in ageing hearts from fatty acid beta oxidation towards glycolysis, was up-regulated, while other genes such
as Mdh1, Shdb, Suclg1, Sucla2 and Dld were down-regulated. (B) Ucp3, a gene encoding an uncoupling protein which protects against
mitochondrial oxidative damage by reducing the production of reactive oxygen species (ROS), was up-regulated, while other genes which
encode adenine nucleotide translocators and proteins in Complex I, Complex II and Complex V in the electron transport chain were down-
regulated.
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induced liver damage based on its ability to up-regulate
hepatic fatty acid beta oxidation. Increased expression of
hepatic genes involved in lipid catabolism has also been
shown to be effected by the catechins of green tea [34]
and the chlorogenic acids of coffee [35].
The up-regulation of genes involved in complement
activation observed in the present study, is similar to
that reported for resveratrol [36]. In the resveratrol
study, complement pathways, both classical and alterna-
tive, as well as acute inflammatory response, were up-
regulated for reasons unknown, although the authors
noted that no evidence of widespread inflammatory
response was observed. The induction of the classical
complement pathway by OPP may be triggered by anti-
bodies, as plant antioxidants were reported to enhance
immunity [37]. As an important component of innate
immunity, complement activation is necessary for pro-
tection against numerous microbial infections [38,39].
Genes involved in ion and electron transport such as
those encoding cytochromes P450 and NADH dehydro-
genase (ubiquinone) Fe-S proteins were also up-regu-
lated by OPP. In general, phenolics may be regarded as
xenobiotics by animal cells and are to some extent trea-
ted as such through interaction with phase I and phase
II detoxification enzyme systems [40]. Phase I detoxifica-
tion in the liver involves the activation of a series of
enzymes called the cytochrome P450 mixed-function
oxidases. These enzymes begin the biotransformation
process by oxidising, reducing or hydrolysing toxins,
thus creating biotransformed intermediates [41]. A
phase I detoxification gene of special interest is Cyp3a4,
which encodes the most abundant cytochrome P450 in
the human liver (around 30%), responsible for 60% of
cytochrome P450-mediated metabolism of drugs in ther-
apeutic use [42]. Cyp3a4 was found to be induced more
than 2-fold by dietary flavonoids such as quercetin and
grape seed extract in HepG2 hepatocytes [42]. Cyp3a11
is the mouse homologue of the human Cyp3a4 [43]. It
Table 2 Genes selected for the real-time qRT-PCR validation experiments
Organ Symbol Definition Accession Assay ID
Liver Cyp3a11 Mus musculus cytochrome P450, family 3, subfamily a, polypeptide 11 NM_007818 Mm00731567_m1
Liver Hmgcs1 Mus musculus 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 NM_145942 Mm00524111_m1
Spleen Vwf Mus musculus Von Willebrand factor homologue NM_011708 Mm00550376_m1
Spleen Brca1 Mus musculus breast cancer 1 NM_009764 Mm00515386_m1
Heart Pdk4 Mus musculus pyruvate dehydrogenase kinase, isoenzyme 4 NM_013743 Mm00443325_m1
Heart Rad21 Mus musculus RAD21 homologue (S. pombe) NM_009009 Mm00485474_m1
All Sfrs9 Mus musculus splicing factor, arginine/serine rich 9 NM_025573 Mm00470546_m1
All Guk1 Mus musculus guanylate kinase 1 NM_008193 Mm00433888_m1
All Hnrpab Mus musculus heterogeneous nuclear ribonucleoprotein A/B NM_010448 Mm00468938_m1
These six target genes were selected based on their presence in significant functions, their differential scores, their detection levels, their presence as single
splice transcripts in microarrays and their availability as Taqman assays designed across splice junctions. Sfrs9, Guk1 and Hnrpab were used as housekeeping
genes as their expression levels were found to be quite stable across treatments in each of the organs tested.
Figure 6 Real-time qRT-PCR validation of microarray data
analysis on the three major organs. (A) Gene expression fold
changes of six target genes as determined by microarray and real-
time qRT-PCR experiments. The direction and magnitude of fold
changes obtained from the real-time qRT-PCR technique were
comparable to those obtained from the microarray technique. # P <
0.05 for gene expression fold changes quantified by real-time PCR
experiments as determined by two-tailed unpaired Student’s t-test.
(B) Correlation of gene expression fold changes between microarray
and real-time qRT-PCR data. Validation of the microarray data via
real-time qRT-PCR shows that correlation of fold changes obtained
by these two gene expression profiling techniques was high with
an R
2 = 0.9653.
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1.68-fold in the mouse liver. Incidentally, Cyp3a11 was
up-regulated in the mouse liver as well by a-tocopherol
[44]. This indicates that OPP has similar effects to other
dietary antioxidants and may thus be involved in drug-
herbal/botanical interaction effects. Phase II detoxifica-
tion enzymes such as UDP glycosyltransferases perform
conjugation reactions which help to convert biotrans-
formed intermediates into less toxic, water-soluble sub-
stances that are easily excreted or eliminated from the
body [41]. In the present study, genes Ugt1a6 and
Ugt1a9 encoding UDP glycosyltransferases were up-
regulated 2.11-fold and 1.95-fold respectively. Comt,t h e
gene which encodes catechol-O-methyltransferase, an
enzyme involved in tyrosine metabolism, was also up-
regulated by OPP. Catechol-O-methyltransferase has
b e e nf o u n dt ob ei n v o l v e di nt h em e t a b o l i s mo fh y d r o -
xytyrosol, the major component of olive phenolics [45].
The up-regulated translation factors involved in protein
synthesis, may also reflect the production of extra
enzymes which help in metabolising OPP.
Other genes up-regulated by OPP are those encoding
chemokine (C-X-C motif) ligand 12 (Cxcl12), gap junc-
tion membrane channel protein beta 1 (Gjb1)a n d
androgen receptor (Ar), which were 1.87-, 1.38- and
2.30-fold increased respectively. Cxcl12 is a gene
encoding a chemokine modulating the progression of
liver fibrosis through its action on hepatic stellate cells
[46], while Gjb1 encodes a gap junction membrane
channel protein which plays an important role in the
regulation of signal transfer and growth control in the
liver. The expression of these genes decreased as liver
diseases progress to cirrhosis and hepatocellular carci-
noma [47]. Both of these genes were down-regulated
by comfrey (Cxcl12 down-regulated 5.26-fold, Gjb1
down-regulated 2.08-fold), a herbal plant containing
pyrrolizidine alkaloids believed to cause hepatotoxicity
in humans and carcinogenicity in animals [46]. Ar was
also down-regulated by comfrey (13.6-fold), as well as
by riddelliine (19.6-fold) which also contains pyrrolizi-
dine alkaloids [48]. Hence, the up-regulation of these
three genes indicates that OPP may have hepatoprotec-
tive effects, and also implies that they do not cause
hepatotoxicity.
Genes involved in cholesterol biosynthesis on the
other hand, were down-regulated by OPP in this study.
Cholesterol is an important constituent of cellular mem-
branes and serves as a precursor in the formation of bile
acids and steroid hormones. Excessive cholesterol how-
ever, is implicated in atherosclerotic lesions and gall-
stone formation [49]. The reduced expression of genes
involved in cholesterol biosynthesis in the mouse liver
s u g g e s t sap o s s i b l er o l eo fO P Pi nr e d u c i n ga t h e r o -
sclerosis and hence, cardiovascular disease. Overall, the
gene expression changes caused by OPP in the liver sug-
gest hepatoprotective and anti-dyslipidaemic effects of
the extract.
OPP up-regulated blood coagulation genes in the spleen
In the spleen, the most interesting genes up-regulated
by OPP were those involved in blood coagulation. The
regulation of these genes suggests that the spleen might
be playing an active protective role in improving blood
circulation and clearing blood clots from the body. OPP
may thus function as anti-thrombotic agents, consider-
ing the fact that as a peripheral lymphoid organ, the
spleen is also involved in mechanical filtration of the
blood to remove unwanted materials [50]. However, this
is still hypothetical and further experiments are required
to show that OPP helps in clearing and not causing
blood clots.
Gene regulation by OPP in the heart showed similarities
with that of caloric restriction
Ageing in the heart involves a transcriptional shift from
fatty acid metabolism to carbohydrate metabolism. This
shift was also found to differentiate maladaptive hyper-
trophy (increased glycolysis) from adaptive or exercise-
induced hypertrophy (increased fatty acid beta oxida-
tion) [51]. A key enzyme, pyruvate dehydrogenase kinase
isoenzyme 4 (Pdk4), inhibits pyruvate dehydrogenase
and thus minimises carbohydrate oxidation by prevent-
ing the flow of glycolytic products into the TCA cycle.
Hence, the up-regulation of Pdk4 in the heart by OPP
may prevent a metabolic shift towards glycolysis and
thus ageing. Another gene, Ucp3, encoding an uncou-
pling protein which protects against mitochondrial oxi-
dative damage by reducing the production of ROS, was
up-regulated in the heart by OPP as well. Ucp3 may
transport fatty acids out of the mitochondria, thereby
protecting the mitochondria from fatty acid anions or
peroxides [52]. Besides up-regulating Pdk4 and Ucp3,
OPP also up-regulated another seven genes in the heart,
carnitine acetyltransferase (Crat), catechol-O-methyl-
transferase (Comt), CCAAT/enhancer binding protein
(Cebpb), enoyl-CoA, hydratase/3-hydroxyacyl CoA dehy-
drogenase (Ehhadh), plasma membrane associated pro-
tein (S3-12), solute carrier family 27 (fatty acid
transporter) (Slc27a1) and xanthine dehydrogenase
(Xdh). Lee et al. (2002) demonstrated the down-regula-
tion of these nine genes in the hearts of ageing B6C3F1
mice [53]. Six of these genes, Pdk4, Ucp3, Comt, Cebpb,
S3-12 and Xdh were significantly up-regulated by caloric
restriction, thus opposing the effects of ageing [53].
Additional genes up-regulated by OPP and also by calo-
ric restriction in the heart include carbonic anhydrase 4
(Car4), carboxylesterase 3 (Ces3), purine-nucleoside
phosphorylase (Pnp) and tumour protein D52-like 1
Leow et al. BMC Genomics 2011, 12:432
http://www.biomedcentral.com/1471-2164/12/432
Page 11 of 17(Tpd52l1) [53]. Hence, a role for OPP in preventing or
slowing down ageing of the heart is implicated.
It was also noted that genes up-regulated in the hearts of
ageing B6C3F1 mice such as aminolevulinic acid synthase
1( Alas1), mature T cell proliferation 1 (Mtcp1) and pro-
tein tyrosine phosphatase 4a2 (Ptp4a2) [53], were down-
regulated by OPP in the heart in the present study. In the
group that had caloric restriction on the other hand, cyclin
D2 (Ccnd2), secreted acidic cysteine rich glycoprotein
(Sparc) and transferrin receptor (Tfrc) genes were down-
regulated [53]. In the present study, these three genes
were also down-regulated by OPP. It has been found that
caloric restriction confers rapid positive effects on the
heart, by rapidly shifting gene expression towards a state
of reduced cardiac remodelling and fibrosis as well as
enhanced contractility [54]. Several plant phenolics such
as resveratrol, quercetin, butein and piceatannol have been
proposed as potential caloric restriction mimetics [1]. The
regulation of genes by OPP in the heart suggests that they
may also act as caloric restriction mimetics.
In addition to genes similarly affected by caloric
restriction, antioxidant genes such as those encoding
erythroid derived-nuclear factor 2-like 1 (Nfe2l1), gluta-
mate-cysteine ligase (Gclm) and various glutathione S-
transferases (Gstm2, Gstm5, Gstm 6)w e r eu p - r e g u l a t e d .
Glutathione S-transferases are important antioxidant
enzymes essential in the detoxification of carcinogens
and scavenging of ROS [40,55,56]. The up-regulation of
these antioxidant genes thus indicates that OPP provides
a higher antioxidant defence in the heart, which is an
organ prone to damage by prooxidants.
The expression levels of genes in the heart TCA cycle,
such as those encoding proteins which produce NADH
(Mdh1)a n dF A D H 2 (Shdb), were also down-regulated.
Suclg1 and Sucla2, genes encoding subunits of succi-
nate-CoA ligases which convert GTP/ATP to GDP/ADP
were also down-regulated. Finally, genes in the electron
transport chain which encode proteins in Complex I,
Complex II and Complex V were down-regulated as
well. Electrons derived from metabolic reducing equiva-
lents (NADH and FADH2) are fed into the electron
transport chain through either Complex I or Complex
II, and eventually pass to molecular oxygen to form
water in Complex IV, while ATP is being formed in
Complex V. These results imply that energy production
in the heart was down-regulated by OPP. Hence, in
reducing the amount of energy generated, OPP may act
as antioxidants in reducing the amount of ROS pro-
duced in the heart, suggesting a beneficial effect of the
extract in preventing cardiac oxidative stress.
Summary and implications of the study
The discovery of OPP opens up a niche for value-added
novel nutraceuticals. In this study, we confirmed that
OPP was not toxic to mice as these compounds did not
significantly alter the organ histology of the animals as
well as their haematology and clinical biochemistry
parameters. In addition, this study identified the global
gene expression profiles caused by OPP in three major
organs of mice on a normal diet. Supplementation of
OPP to these mice resulted in numerous beneficial bio-
logical activities during healthy states. In livers of these
mice, lipid catabolism genes were up-regulated while
cholesterol biosynthesis genes were down-regulated,
suggesting that OPP may find potential applications as
hepatoprotective and anti-dyslipidaemic supplements.
OPP may also act as possible anti-thrombotic agents
s i n c et h e ye n c o u r a g e dt h ea g g r e g a t i o no fp l a t e l e t si n
spleens. OPP also retarded the ageing process in hearts,
similar to the effects of caloric restriction.
Although the clinical biochemistry parameters on lipid
profiles (triglycerides, total cholesterol, low-density lipo-
proteins and high-density lipoproteins) measured in this
study did not show any significant differences between
the groups, mice in the treatment group did show a
delay in weight gain throughout the six weeks of feeding
compared to the control group. Also, while the blood
serum lipid profiles measured in the present study did
not show any significant differences between the control
and treated mice even though the hepatic gene expres-
sion profiles had changed, a similar observation was
made by Matsui et al. (2005) when cocoa was given to
mice [57]. In this previous study, cocoa ingestion
increased total cholesterol concentrations in the blood
sera, whereas body weight gain and hepatic cholesterol
biosynthesis were decreased [57]. Hence, the difference
between the clinical biochemistry parameters and the
hepatic gene expression changes observed in the present
study might be caused by other factors, which include
reabsorption of cholesterol in the small intestine or
other roles that the small intestine may play in the
aetiology of obesity [58]. Perhaps the lipid profiles of
livers in addition to blood sera should be conducted in
future studies in order to directly correlate these profiles
with the hepatic gene expression changes observed.
T oo u rk n o w l e d g e ,t h i si st h ef i r s ts t u d yi nw h i c h
microarray analysis has been carried out on major
organs of mice supplemented with OPP. In identifying
possible pharmacological, nutraceutical or toxicological
responses, the biological representation of a set of genes
is more interesting than the genes themselves. By using
different microarray softwares for statistical and func-
tional analyses, we identified genes, gene ontologies,
pathways and networks that were significantly changed
by OPP in different major organs of mice on a normal
diet. The gene expression profiles obtained indicate sev-
eral mechanisms as to how OPP exerts its beneficial
effects in vivo. These findings implicate broader
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study also serves as a model for the dissection of many
other complex responses mediated by dietary phenolics
and plant phytochemicals in general.
Conclusions
Our study was designed to understand the global func-
tional profiles of OPP in mice which were on a normal
d i e t .T h i sa n a l y s i ss h o w ss o m eo ft h em o l e c u l a r
mechanisms as to how OPP exerts biological activities
in vivo during healthy states. It thus provides a back-
ground for further hypotheses to be tested in future
experiments involving OPP specifically, and dietary phe-
nolics in general. This study also sets the scene for iden-
tifying the molecular modes of action involved in
conferring the positive biological effects of OPP during
various diseased states.
Methods
OPP samples
The OPP samples used in this study were prepared
according to the methods described in Sambantha-
murthi et al. (2008) [19]. OPP contains numerous phe-
nolic acids, with three isomers of caffeoylshikimic acid
as major components [20,21]. Other phenolic acids pre-
sent include protocatechuic acid and p-hydroxybenzoic
acid. The detailed composition of OPP is as described
earlier [21].
Animals, diets and treatments
All male inbred BALB/c mice which were designated for
this study (n=2 0 ) were purchased from the Institute of
Medical Research, Kuala Lumpur, Malaysia, at around
five weeks of age just after weaning. All animal proce-
dures were approved by the Animal Care and Use Com-
mittee of the University of Malaya, Kuala Lumpur,
Malaysia. The animals were randomly assigned into
cages (n=5per cage) and acclimatised for one week,
during which a standard chow diet purchased from the
University of Malaya and distilled water, were given. At
the start of the experiment, the diet of the animals was
changed to a custom-made normal diet (58.2% kcal/kcal
carbohydrate, 27.2% kcal/kcal protein and 14.6% kcal/
kcal fat, including cellulose, mineral mix, vitamin mix
and DL-methionine).
The control group (n=1 0 ) was supplemented with
distilled water while the treatment group (n=1 0 )w a s
supplemented with OPP, as drinking fluids ad libitum.
The antioxidant content of the OPP given was 1500
ppm gallic acid equivalent. Food and fluids were chan-
ged daily. During the animal feeding process, body
weights were monitored every week, while fluid intake
was monitored every day, for six weeks. Food intake and
faecal output were monitored for seven consecutive days
between week two to week three.
After six weeks, the mice were sacrificed via euthana-
sia with diethyl ether followed by exsanguination. Blood
samples were collected after an overnight food fast (with
fluids still provided) via cardiac puncture, while three
major organs including livers, spleens and hearts were
excised, rinsed in 0.9% w/v sodium chloride solution
and weighed. Half of the organs (n=5 ) were preserved
in 10% formalin diluted with phosphate buffered saline
for histology analysis, while the other half (n=5 )w e r e
snap-frozen in liquid nitrogen and stored at -80°C until
the total RNA extraction process for gene expression
analysis.
Haematology analysis on blood samples
About 200 μL from half of each blood sample collected
(n=4 ) was aliquoted into a blood collection tube con-
taining ethylenediaminetetraacetic acid to prevent clot-
ting. These whole blood samples were sent immediately
after dissection of the animals to the Clinical Biochemis-
try and Haematology Laboratory, Department of Veter-
inary Pathology and Microbiology, Faculty of Veterinary
Medicine, University of Putra Malaysia, Serdang, Selan-
gor, Malaysia, for haematology analysis. The analysis
was carried out using the Animal Blood Counter Vet
Haematology Analyser (Horiba ABX, France).
Clinical biochemistry analysis on blood samples
In order to obtain sera, blood samples were allowed to
clot at room temperature for two hours before being
centrifuged at 1000 xg for five minutes, after which the
supernatant layers were collected and stored at -20°C.
The blood serum samples obtained were then sent for
clinical biochemistry analysis using the Roche/Hitachi
902 Chemistry Analyser (Roche/Hitachi, Switzerland) in
the Clinical Biochemistry and Haematology Laboratory,
Department of Veterinary Pathology and Microbiology,
Faculty of Veterinary Medicine, University of Putra
Malaysia. Clinical biochemistry parameters which were
examined include alanine aminotransferase, aspartate
aminotransferase, glucose, serum total protein, albumin,
globulin, ratio of albumin to globulin, total cholesterol,
triglycerides, low-density lipoproteins and high-density
lipoproteins. Of a total of ten serum samples per group
obtained for clinical biochemistry analysis, two samples
in the control group and three samples in the treatment
group were excluded due to blood lysis.
Histology analysis on organs
Histology analysis on dissected organs (n=5 ) preserved
in 10% buffered formalin was carried out in the Depart-
ment of Pathology, Faculty of Medicine, University of
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toxylin and eosin staining.
Total RNA extraction for gene expression analysis
All precautions in handling RNA were taken in this
study. Total RNA isolation from mouse organs (n=5 )
was carried out using the RNeasy Mini Kit (Qiagen,
Inc., Valencia, CA) and QIAshredder homogenizers
(Qiagen, Inc., Valencia, CA), preceded by grinding in
liquid nitrogen using mortars and pestles. The total
RNA samples obtained were subjected to NanoDrop
1000A Spectrophotometer (Thermo Fisher Scientific,
Waltham, MA) measurement for yield and purity assess-
ment. Integrity of the total RNA samples was assessed
using the Agilent 2100 Bioanalyzer (Agilent Technolo-
gies, Santa Clara, CA) and Agilent RNA 6000 Nano
Chip Assay Kit (Agilent Technologies, Santa Clara, CA).
Four total RNA samples with the highest RNA Integrity
Numbers and 28S/18S rRNA ratios within each condi-
tion (either control or treatment) were then selected for
microarray studies.
Microarray hybridisation, washing and scanning
Amplification of total RNA samples which were of high
yield, purity and integrity was carried out using the Illu-
mina TotalPrep RNA Amplification Kit (Ambion, Inc.,
A u s t i n ,T X ) .T h ec R N Ap r o d u c e dw a st h e nh y b r i d i s e d
to the Illumina MouseRef-8 Version 1 Expression Bead-
Chip (Illumina, Inc., San Diego, CA), using the Direct
Hybridization Kit (Illumina, Inc., San Diego, CA).
Microarray hybridisation, washing and scanning were
carried out according to the manufacturer’s instructions.
The raw gene expression data obtained are available at
Gene Expression Omnibus [59] (Accession number:
GSE28824).
Microarray data analysis
Quality control of the hybridisation, microarray data
extraction and initial analysis were carried out using the
Illumina BeadStudio software (Illumina, Inc., San Diego,
CA). Outlier samples were removed via hierarchical
clustering analysis provided by the Illumina BeadStudio
software and also using the TIGR MeV software (Insti-
tute for Genomic Research, Rockville, MD) [60], via dif-
ferent distance metrics. A minimum of three biological
replicates per condition (with outliers removed) was
then considered for further analysis. For livers, four
replicates in the control group and three replicates in
the treatment group were analysed. For spleens and
hearts respectively, four replicates in the control group
and four replicates in the treatment group were
analysed.
Gene expression values were normalised using the
r a n ki n v a r i a n tm e t h o da n dg e n e sw h i c hh a dD e t e c t i o n
Levels of more than 0.99 in either the control or treat-
ment samples were considered significantly detected. To
filter the data for genes which changed significantly in
terms of statistics, the Illumina Custom error model was
used and genes were considered significantly changed at
a| D i f f e r e n t i a lS c o r e |o fm o r et h a n2 0 ,w h i c hw a s
equivalent to a P Value of less than 0.01 [61].
The genes and their corresponding data were then
exported into the Microsoft Excel software (Microsoft
Corporation, Richmond, WA) for further analysis. To
calculate fold changes, an arbitrary value of 10 was
given to expression values which were less than 10. Fold
changes were then calculated by dividing the mean
values of Signal Y (treatment) with those of Signal ×
(control) if the genes were up-regulated and vice versa if
the genes were down-regulated. Two-way (gene and
sample) hierarchical clustering of the significant genes
was then performed using the TIGR MeV software to
ensure that the replicates of each condition were clus-
tered to each other. The Euclidean distance metric and
average linkage method were used to carry out the hier-
archical clustering analysis.
Changes in biological pathways and gene ontologies
were assessed via functional enrichment analysis, using
the GenMAPP [24] and MAPPFinder [25] softwares
(University of California at San Francisco, San Francisco,
CA). The MAPPFinder software ranks GenMAPPs
(pathways) and gene ontologies based on the hypergeo-
metric distribution. Readers are referred to Doniger et
al. (2003) [25] for further explanations of the terms
used in the MAPPFinder software. GenMAPPs and gene
ontologies which had Permuted P Values of less than
0.01, Numbers of Genes Changed of more than or equal
to 2 and Z Scores of more than 2 were considered
significant.
It should be noted that the MAPPFinder software
clusters multiple probes for a distinct gene into a single
gene grouping in order to calculate the number of dis-
tinct genes which meet the user-defined criteria, not the
probes. In this study, up-regulated and down-regulated
genes were analysed separately in the functional enrich-
ment analysis but were viewed together in each Gen-
MAPP. Boxes coloured yellow indicate genes which
were up-regulated while those coloured blue indicate
genes which were down-regulated. The fold changes are
indicated next to the boxes. Individual boxes which have
different shadings within them indicate the presence of
multiple probes (splice transcripts) within a single gene.
Changes in regulatory networks were also analysed
through the use of the Ingenuity Pathways Analysis soft-
ware (Ingenuity
® Systems, Redwood City, CA) [26]. For
each organ, a dataset containing differentially expressed
genes and their corresponding fold changes was
uploaded into the application. Analyses of up-regulated
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Each gene identifier was mapped to its corresponding
gene object in the Ingenuity Pathways Knowledge Base.
These genes were overlaid onto a global molecular net-
work developed from information contained in the Inge-
nuity Pathways Knowledge Base. Networks of these
focus genes were then algorithmically generated based
on their connectivity.
A network is a graphical representation of the molecu-
lar relationships between genes or gene products. Genes
or gene products were represented as nodes, and the
biological relationship between two nodes was repre-
sented as an edge (line). The intensity of the node col-
our indicates the degree of up-regulation (red) or down-
regulation (green). Nodes were displayed using various
shapes that represented the functional class of the gene
product. Edges were displayed with various labels that
described the nature of the relationship between the
nodes.
Real-time qRT-PCR validation
Two-step real-time qRT-PCR studies were carried out
on six target genes selected to represent the different
organs used in the microarray experiments, using Taq-
Man Gene Expression Assays (Applied Biosystems, Fos-
ter City, CA). These genes were selected based on their
presence in significant functions, their differential
scores, their detection levels, their presence as single
splice transcripts in microarrays and their availability as
Taqman assays designed across splice junctions. The
same aliquots of total RNA samples used in the micro-
array experiments were utilised for this analysis. Primer
and probe sets for the selected genes were obtained
from the Applied BiosystemsI n v e n t o r i e dA s s a y s - O n -
Demand (Applied Biosystems, Foster City, CA).
Briefly, reverse transcription to generate first-strand
cDNA from total RNA was carried out using the High-
Capacity cDNA Reverse Transcription Kit (Applied Bio-
systems, Foster City, CA). Real-time PCR was then car-
ried out on the first-strand cDNA generated using a 25
μL reaction volume in an Applied Biosystems 7000
Real-Time PCR System (Applied Biosystems, Foster
City, CA), with the following conditions: 50°C, 2 min-
utes, 1 cycle; 95°C, 10 minutes, 1 cycle; 95°C, 15 seconds
and 60°C, 1 minute, 40 cycles. For gene expression
experiments, reactions for each biological replicate and
non-template control (NTC) were carried out in dupli-
cates. For amplification efficiency determination, reac-
tions were carried out in triplicates.
Quality control of the replicates used, real-time qRT-
PCR data extraction and initial analysis were carried out
using the 7000 Sequence Detection System software
(Applied Biosystems, Foster City, CA). A manual thresh-
old of 0.6000 and an auto baseline were applied in order
to obtain the threshold cycle (Ct) for each measurement
taken. The threshold was chosen as it intersected the
exponential phase of the amplification plots [62]. The
criteria for quality control of the data obtained include
ΔCt of less than 0.5 between technical replicates and
ΔCt of more than 5.0 between samples and NTCs [63].
Relative quantification of the target genes of interest
was carried out using the qBase 1.3.5 software (Center
for Medical Genetics, Ghent University Hospital, Ghent,
Belgium) [64], which takes into account the calculations
of amplification efficiencies and multiple housekeeping
genes. Expression levels of target genes were normalised
to the geometric mean of three housekeeping genes,
arginine/serine rich splicing factor 9 (Sfrs9), guanylate
kinase 1 (Guk1) and heterogeneous nuclear ribonucleo-
protein A/B (Hnrpab). These genes were chosen as they
were shown to be stable across the previously obtained
microarray data, and confirmed to be more stable than
18S ribosomal RNA (18SrRNA), via the usage of the
geNorm 3.5 software (Center for Medical Genetics,
Ghent University Hospital, Ghent, Belgium) [65].
Statistical analysis
Statistical analysis was carried out by using the two-
tailed unpaired Student’s t-test available in the Microsoft
Excel software (Microsoft Corporation, Redmond, WA)
unless otherwise stated. Differences with P Values of
less than 0.05 were considered statistically significant.
Additional material
Additional file 1: List of genes significantly changed in the liver,
spleen and heart by OPP. The |Differential Score| for all genes is more
than 20, equivalent to a P Value of less than 0.01.
Additional file 2: An example of the two-way hierarchical clustering
analysis carried out on microarray data (using data from the liver
as an example). In this figure, single colour gene expression values are
represented using a blue-white-yellow (0 to positive) colour scheme.
Grey boxes indicate negative values. Note that the replicates of each
group (LA1, LA2, LA4, LA5 in the control group and LB1, LB2, LB4 in the
treatment group) were clustered together within each group but
separated from the other group, indicating that the gene expression
values selected as significantly changed differentiated the two groups.
Additional file 3: List of GenMAPPs and gene ontologies
significantly changed in the liver, spleen and heart by OPP. All
GenMAPPs and gene ontologies had Permuted P Values of less than
0.01, Numbers of Genes Changed of more than or equal to 2 and Z
Scores of more than 2.
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ADP: adenosine diphosphate; ATP: adenosine triphosphate; CCAAT: cytidine-
cytidine-adenosine-adenosine-thymidine; CoA: coenzyme A; cDNA:
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